[go: up one dir, main page]

IL165525A0 - Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions - Google Patents

Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Info

Publication number
IL165525A0
IL165525A0 IL16552504A IL16552504A IL165525A0 IL 165525 A0 IL165525 A0 IL 165525A0 IL 16552504 A IL16552504 A IL 16552504A IL 16552504 A IL16552504 A IL 16552504A IL 165525 A0 IL165525 A0 IL 165525A0
Authority
IL
Israel
Prior art keywords
intermediates
manufacturing
pharmaceutical compositions
dihydropyridine derivative
derivative suitable
Prior art date
Application number
IL16552504A
Other languages
English (en)
Original Assignee
Motivan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motivan Ltd filed Critical Motivan Ltd
Priority to IL16552504A priority Critical patent/IL165525A0/xx
Priority to EP05812950A priority patent/EP1824824A1/fr
Priority to PCT/IL2005/001290 priority patent/WO2006059332A1/fr
Publication of IL165525A0 publication Critical patent/IL165525A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
IL16552504A 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions IL165525A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions
EP05812950A EP1824824A1 (fr) 2004-12-02 2005-12-01 Intermédiaires de synthèse de la lercanidipine
PCT/IL2005/001290 WO2006059332A1 (fr) 2004-12-02 2005-12-01 Intermédiaires de synthèse de la lercanidipine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL165525A0 true IL165525A0 (en) 2006-01-15

Family

ID=35945255

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16552504A IL165525A0 (en) 2004-12-02 2004-12-02 Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions

Country Status (3)

Country Link
EP (1) EP1824824A1 (fr)
IL (1) IL165525A0 (fr)
WO (1) WO2006059332A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007031865A2 (fr) * 2005-09-16 2007-03-22 Glenmark Pharmaceuticals Limited Forme polymorphique d'hydrochlorure de lercanidipine et son procede de preparation
CN102020602B (zh) * 2009-09-18 2013-12-25 深圳信立泰药业股份有限公司 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8403866D0 (en) * 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
US5767136A (en) * 1995-05-12 1998-06-16 Recordati, S.A. Chemical And Pharmaceutical Company 1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls

Also Published As

Publication number Publication date
EP1824824A1 (fr) 2007-08-29
WO2006059332A1 (fr) 2006-06-08

Similar Documents

Publication Publication Date Title
GB0219896D0 (en) Dihydropyridine derivatives
GB0403247D0 (en) A pharmaceutical composition
IL175860A0 (en) Method for the production of a solid, orally applicable pharmaceutical composition
IL182703A (en) Pharmaceuticals containing camptothecin derivatives
EP1765283A4 (fr) Compositions pharmaceutiques
IL228730A (en) Pharmaceutical manufacturing process
IL175973A0 (en) Pharmaceutical compositions comprising lercanidipine
ZA200702418B (en) Taste-masking Pharmaceutical compositions
ZA200700685B (en) Novel piperidine derivative for the treatment of depression
GB0405033D0 (en) Novel pharmaceutical compositions
IL181766A0 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
IL180893A (en) Method for the preparation of a d-erythro-2,2-difluoro-2-deoxy-1-oxoribose derivative
GB0406378D0 (en) Novel pharmaceutical compositions
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
IL186862A0 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
PL1729739T3 (pl) Sposób wytwarzania stałej kompozycji farmaceutycznej
IL182955A0 (en) Pharmaceutical compositions comprising a benzothiazol derivative and their use
GB0406380D0 (en) Novel pharmaceutical compositions
IL181938A0 (en) Lercanidipine capsules
EP1805154A4 (fr) Compositions pharmaceutiques
GB0400452D0 (en) A pharmaceutical composition
IL165525A0 (en) Intermediates and a process for the manufacturing for antihypertensive dihydropyridine derivative suitable for pharmaceutical compositions
EP1736474A4 (fr) Dérivé de pipéridine
GB0407351D0 (en) Pharmaceutical compositions
GB0400971D0 (en) Pharmaceutical compositions